Filed in a Delaware federal court, the lawsuits claim the companies copied technology developed by Bayer's subsidiary, ...

Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 –-- ...

Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 - -- Expects to initiate global Phase 1/2 MAD clinical study ...

A UGM researcher warns that super flu cases in Indonesia require close monitoring despite no signs of increased severity.

Exelixis, Inc. today announced its preliminary unaudited financial results for the fiscal year 2025, provided financial guidance for fiscal year 2026 and delivered an update on its business. Exelixis ...

Kazia Therapeutics today announced that its Chief Executive Officer, John Friend, MD, will be in San Francisco next week to ...

From eradicating smallpox to battling the COVID-19 pandemic, these vaccine pioneers have helped make colossal strides in ...

First discovered in the 1950s, NGF is now known to direct the growth, maintenance, proliferation and preservation of neurons ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Fidelity Select Health Care Portfolio outperformed its benchmark in Q3 2025 thanks to strong healthcare stocks. Review the ...

Economic uncertainty, discrimination, and unreliable access to food considerably raise Long COVID risk in children. Social ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, ...